A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy

Platinum-based chemotherapy is a primary treatment of choice for advanced non-small-cell lung cancer (NSCLC). Analytical methods to specifically evaluate biomarkers predictive of therapeutic efficacy have not been developed. Two randomized phase III trials of carboplatin-based chemotherapy in advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Bepler, Gerold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859458/
https://www.ncbi.nlm.nih.gov/pubmed/24349760
http://dx.doi.org/10.3390/jpm3030251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859458/
https://www.ncbi.nlm.nih.gov/pubmed/24349760
http://dx.doi.org/10.3390/jpm3030251

Ejemplares similares